Annual D&A
$298.50 K
-$2800.00-0.93%
December 31, 2023
Summary
- As of February 21, 2025, ONCY annual depreciation & amortization is $298.50 thousand, with the most recent change of -$2800.00 (-0.93%) on December 31, 2023.
- During the last 3 years, ONCY annual D&A has fallen by -$34.40 thousand (-10.33%).
- ONCY annual D&A is now -68.18% below its all-time high of $938.20 thousand, reached on December 31, 2007.
Performance
ONCY Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
September 30, 2024
Summary
- ONCY quarterly depreciation & amortization is not available.
Performance
ONCY Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
September 30, 2024
Summary
- ONCY TTM depreciation & amortization is not available.
Performance
ONCY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
ONCY Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.9% | - | - |
| 3 y3 years | -10.3% | - | - |
| 5 y5 years | +305.6% | - | - |
ONCY Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.2% | at low | ||||
| 5 y | 5-year | -18.4% | at low | ||||
| alltime | all time | -68.2% | >+9999.0% |
Oncolytics Biotech Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $298.50 K(-0.9%) | $77.90 K(+1.0%) | $298.50 K(+0.3%) |
| Sep 2023 | - | $77.10 K(+7.4%) | $297.50 K(+2.1%) |
| Jun 2023 | - | $71.80 K(+0.1%) | $291.40 K(-1.5%) |
| Mar 2023 | - | $71.70 K(-6.8%) | $295.70 K(-1.9%) |
| Dec 2022 | $301.30 K(-16.4%) | $76.90 K(+8.3%) | $301.30 K(-0.6%) |
| Sep 2022 | - | $71.00 K(-6.7%) | $303.00 K(+3.2%) |
| Jun 2022 | - | $76.10 K(-1.6%) | $293.60 K(-17.0%) |
| Mar 2022 | - | $77.30 K(-1.7%) | $353.60 K(-1.9%) |
| Dec 2021 | $360.50 K(+8.3%) | $78.60 K(+27.6%) | $360.50 K(-0.1%) |
| Sep 2021 | - | $61.60 K(-54.7%) | $360.70 K(-7.1%) |
| Jun 2021 | - | $136.10 K(+61.6%) | $388.10 K(+16.9%) |
| Mar 2021 | - | $84.20 K(+6.9%) | $332.00 K(-0.3%) |
| Dec 2020 | $332.90 K(-9.0%) | $78.80 K(-11.5%) | $332.90 K(-2.0%) |
| Sep 2020 | - | $89.00 K(+11.3%) | $339.60 K(-0.1%) |
| Jun 2020 | - | $80.00 K(-6.0%) | $340.10 K(-1.8%) |
| Mar 2020 | - | $85.10 K(-0.5%) | $346.30 K(-5.3%) |
| Dec 2019 | $365.90 K(+397.1%) | $85.50 K(-4.5%) | $365.80 K(+21.1%) |
| Sep 2019 | - | $89.50 K(+3.8%) | $302.10 K(+29.9%) |
| Jun 2019 | - | $86.20 K(-17.6%) | $232.60 K(+43.2%) |
| Mar 2019 | - | $104.60 K(+379.8%) | $162.40 K(+121.0%) |
| Dec 2018 | $73.60 K(+5.1%) | $21.80 K(+9.0%) | $73.50 K(+12.0%) |
| Sep 2018 | - | $20.00 K(+25.0%) | $65.60 K(+1.4%) |
| Jun 2018 | - | $16.00 K(+1.9%) | $64.70 K(-4.1%) |
| Mar 2018 | - | $15.70 K(+12.9%) | $67.50 K(-3.6%) |
| Dec 2017 | $70.00 K(-42.9%) | $13.90 K(-27.2%) | $70.00 K(-7.2%) |
| Sep 2017 | - | $19.10 K(+1.6%) | $75.40 K(-15.5%) |
| Jun 2017 | - | $18.80 K(+3.3%) | $89.20 K(-16.8%) |
| Mar 2017 | - | $18.20 K(-5.7%) | $107.20 K(-12.5%) |
| Dec 2016 | $122.50 K(-13.4%) | $19.30 K(-41.3%) | $122.50 K(-13.5%) |
| Sep 2016 | - | $32.90 K(-10.6%) | $141.60 K(+2.2%) |
| Jun 2016 | - | $36.80 K(+9.9%) | $138.50 K(+0.1%) |
| Mar 2016 | - | $33.50 K(-12.8%) | $138.40 K(-2.1%) |
| Dec 2015 | $141.40 K(-4.5%) | $38.40 K(+28.9%) | $141.30 K(-0.9%) |
| Sep 2015 | - | $29.80 K(-18.8%) | $142.60 K(-4.7%) |
| Jun 2015 | - | $36.70 K(+0.8%) | $149.60 K(+0.7%) |
| Mar 2015 | - | $36.40 K(-8.3%) | $148.60 K(+0.3%) |
| Dec 2014 | $148.10 K(+15.9%) | $39.70 K(+7.9%) | $148.20 K(-0.1%) |
| Sep 2014 | - | $36.80 K(+3.1%) | $148.40 K(-1.4%) |
| Jun 2014 | - | $35.70 K(-0.8%) | $150.50 K(+8.0%) |
| Mar 2014 | - | $36.00 K(-9.8%) | $139.40 K(+9.1%) |
| Dec 2013 | $127.80 K(+16.9%) | $39.90 K(+2.6%) | $127.80 K(+13.2%) |
| Sep 2013 | - | $38.90 K(+58.1%) | $112.90 K(+11.5%) |
| Jun 2013 | - | $24.60 K(+0.8%) | $101.30 K(-4.2%) |
| Mar 2013 | - | $24.40 K(-2.4%) | $105.70 K(-3.3%) |
| Dec 2012 | $109.30 K(+16.8%) | $25.00 K(-8.4%) | $109.30 K(+1.2%) |
| Sep 2012 | - | $27.30 K(-5.9%) | $108.00 K(+6.1%) |
| Jun 2012 | - | $29.00 K(+3.6%) | $101.80 K(-2.2%) |
| Mar 2012 | - | $28.00 K(+18.1%) | $104.10 K(+11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $93.60 K(+52.9%) | $23.70 K(+12.3%) | $93.60 K(+7.1%) |
| Sep 2011 | - | $21.10 K(-32.6%) | $87.40 K(+7.4%) |
| Jun 2011 | - | $31.30 K(+78.9%) | $81.40 K(+26.2%) |
| Mar 2011 | - | $17.50 K(0.0%) | $64.50 K(+5.2%) |
| Dec 2010 | $61.20 K(-71.7%) | $17.50 K(+15.9%) | $61.30 K(+22.4%) |
| Sep 2010 | - | $15.10 K(+4.9%) | $50.10 K(-17.3%) |
| Jun 2010 | - | $14.40 K(+0.7%) | $60.60 K(-57.9%) |
| Mar 2010 | - | $14.30 K(+127.0%) | $143.90 K(-33.4%) |
| Dec 2009 | $216.30 K(-44.0%) | $6300.00(-75.4%) | $216.20 K(-28.4%) |
| Sep 2009 | - | $25.60 K(-73.8%) | $302.00 K(-18.0%) |
| Jun 2009 | - | $97.70 K(+12.8%) | $368.50 K(+76.6%) |
| Mar 2009 | - | $86.60 K(-6.0%) | $208.70 K(-46.0%) |
| Dec 2008 | $386.40 K(-58.8%) | $92.10 K(0.0%) | $386.30 K(-25.8%) |
| Sep 2008 | - | $92.10 K(-248.3%) | $520.70 K(-45.6%) |
| Jun 2008 | - | -$62.10 K(-123.5%) | $957.60 K(-4.0%) |
| Mar 2008 | - | $264.20 K(+16.6%) | $997.00 K(+6.3%) |
| Dec 2007 | $938.20 K(+14.8%) | $226.50 K(-57.2%) | $938.30 K(+2.8%) |
| Sep 2007 | - | $529.00 K(-2430.4%) | $912.40 K(+54.2%) |
| Jun 2007 | - | -$22.70 K(-111.0%) | $591.80 K(-28.4%) |
| Mar 2007 | - | $205.50 K(+2.4%) | $827.10 K(+1.2%) |
| Dec 2006 | $817.00 K(+15.6%) | $200.60 K(-3.7%) | $817.00 K(+2.5%) |
| Sep 2006 | - | $208.40 K(-2.0%) | $797.30 K(+2.2%) |
| Jun 2006 | - | $212.60 K(+8.8%) | $780.50 K(+6.3%) |
| Mar 2006 | - | $195.40 K(+8.0%) | $734.20 K(+3.9%) |
| Dec 2005 | $706.80 K(+22.1%) | $180.90 K(-5.6%) | $706.80 K(+23.9%) |
| Sep 2005 | - | $191.60 K(+15.2%) | $570.30 K(-11.7%) |
| Jun 2005 | - | $166.30 K(-1.0%) | $645.60 K(+5.7%) |
| Mar 2005 | - | $168.00 K(+278.4%) | $611.00 K(+5.6%) |
| Dec 2004 | $578.80 K(+21.9%) | $44.40 K(-83.4%) | $578.80 K(-11.7%) |
| Sep 2004 | - | $266.90 K(+102.7%) | $655.50 K(+27.5%) |
| Jun 2004 | - | $131.70 K(-3.0%) | $514.00 K(+1.2%) |
| Mar 2004 | - | $135.80 K(+12.1%) | $507.70 K(+7.0%) |
| Dec 2003 | $474.70 K(+29.7%) | $121.10 K(-3.4%) | $474.70 K(+5.2%) |
| Sep 2003 | - | $125.40 K(0.0%) | $451.30 K(-10.3%) |
| Jun 2003 | - | $125.40 K(+22.0%) | $503.20 K(+30.3%) |
| Mar 2003 | - | $102.80 K(+5.2%) | $386.10 K(+5.5%) |
| Dec 2002 | $365.90 K(+21.7%) | $97.70 K(-44.9%) | $365.80 K(+5.4%) |
| Sep 2002 | - | $177.30 K(+2036.1%) | $346.90 K(+40.6%) |
| Jun 2002 | - | $8300.00(-89.9%) | $246.70 K(-20.8%) |
| Mar 2002 | - | $82.50 K(+4.7%) | $311.30 K(+3.6%) |
| Dec 2001 | $300.60 K(+117.5%) | $78.80 K(+2.2%) | $300.60 K(+3.4%) |
| Sep 2001 | - | $77.10 K(+5.8%) | $290.80 K(+3.5%) |
| Jun 2001 | - | $72.90 K(+1.5%) | $281.10 K(+34.4%) |
| Mar 2001 | - | $71.80 K(+4.1%) | $209.10 K(+51.4%) |
| Dec 2000 | $138.20 K(>+9900.0%) | $69.00 K(+2.4%) | $138.10 K(+99.9%) |
| Sep 2000 | - | $67.40 K(+7388.9%) | $69.10 K(+3964.7%) |
| Jun 2000 | - | $900.00(+12.5%) | $1700.00(+112.5%) |
| Mar 2000 | - | $800.00 | $800.00 |
| Dec 1999 | $1100.00 | - | - |
FAQ
- What is Oncolytics Biotech annual depreciation & amortization?
- What is the all time high annual D&A for Oncolytics Biotech?
- What is Oncolytics Biotech annual D&A year-on-year change?
- What is the all time high quarterly D&A for Oncolytics Biotech?
- What is the all time high TTM D&A for Oncolytics Biotech?
What is Oncolytics Biotech annual depreciation & amortization?
The current annual D&A of ONCY is $298.50 K
What is the all time high annual D&A for Oncolytics Biotech?
Oncolytics Biotech all-time high annual depreciation & amortization is $938.20 K
What is Oncolytics Biotech annual D&A year-on-year change?
Over the past year, ONCY annual depreciation & amortization has changed by -$2800.00 (-0.93%)
What is the all time high quarterly D&A for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly depreciation & amortization is $529.00 K
What is the all time high TTM D&A for Oncolytics Biotech?
Oncolytics Biotech all-time high TTM depreciation & amortization is $997.00 K